市场调查报告书
商品编码
1400698
全球药局自动化市场评估:依产品、药局规模、应用、最终用户、地区、机会、预测(2017-2031)Global Pharmacy Automation Market Assessment, By Product, By Pharmacy Size, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球药局自动化市场规模预计到2023年将达到65.1亿美元,到2031年将达到113.1亿美元,2024-2031年预测期间复合年增长率为7.15%。
由于需要最大限度地减少用药错误,近年来市场出现了显着的成长和发展。手动药物处理和分配增加了出错的可能性并阻碍了患者的依从性。处方量的增加、疾病盛行率的增加、自动化程度的提高、卫生系统中的 EHR 合规性以及改进工作流程和成本效率的需求正在推动对药房自动化的需求。
药房自动化系统与电子健康记录 (EHR) 等医疗保健 IT 系统的整合可以提高医疗保健系统的互通性。多个市场参与者正在提出创新的解决方案来自动化药局工作流程,进一步推动市场发展。此外,药房自动化市场的最新发展集中在提高可靠性、准确性和易用性。
在零售製药业,慢性病流行需要自动化来改善工作流程并提高效率。慢性病的流行导致药局柜檯的处方量增加。由于人力有限,处理起来是一个很大的挑战。药局自动化可以帮助您轻鬆处理大量处方,并确保患者以最小的错误收到药物。《Frontiers》发表的一篇论文显示,到2035年,50岁以上的成年人口中,35.66%将患有至少一种慢性病,预计到2050年这一比例将上升至47.81%。因此,慢性病的流行和处方量的增加是市场的驱动因素。
近年来,全球药局自动化市场的投资趋势增加。许多市场公司正在开发自动化工具,以推动药局自动化的创新和生产力。利害关係人正在开发高效的药房自动化解决方案,以解决当前处方量大和人员短缺等缺点。私营和公共部门预测投资成长和回报前景广阔。
2023 年 10 月,Plenful 获得了 900 万美元的投资,这是一家总部位于旧金山的公司,为药剂师提供工作流程工具,以自动执行手动和管理任务。该公司表示已与 20 多家客户签约,并完成了由 Bessemer Venture Partners 领投的 900 万美元投资。
疫情对全球药局自动化市场产生了正面影响。疫情对采用药局自动化以减少药师的工作量产生了强烈需求。COVID-19 大流行导致处方数量迅速增加,从而增加了对药房自动化的需求,以确保在有限的人员的情况下及时配药。疫情期间,药局自动化带来了速度、准确性和可靠性等优势。由于劳动力和物资短缺,大流行期间对处方药的需求很高。疫情期间药局自动化的成功让业界意识到其重要性,进而推动药局自动化技术的进一步成长。
本报告研究和分析了全球製药自动化市场,提供市场规模和预测、市场动态以及主要参与者的现状和前景。
Global pharmacy automation market size was valued at USD 6.51 billion in 2023, which is expected to reach USD 11.31 billion in 2031, with a CAGR of 7.15% for the forecast period between 2024 and 2031F. Since the coronavirus pandemic, the pharmaceutical industry began to see more reasons to reduce handling errors and boost service delivery. After years of development and research, pharmacy automation was the answer. Following the COVID-19 pandemic, the pharmaceutical sector started prioritizing solutions to improve service delivery and reduce handling errors.
The pharmacy automation market has showcased significant growth and development in recent years attributed to the need to minimize medication errors. Manual handling of medications and their dispensing increases the chance of error, leading to barriers in patient compliance. The increasing prescription volume, growing disease prevalence, increasing automation, EHR compliance in healthcare system, need for increasing workflow and cost efficiency have fueled the demand for pharmacy automation.
Integration of pharmacy automation systems with electronic health records (EHR) and other healthcare IT systems will enable better interoperability in healthcare systems. Several market players are producing innovative solutions to automate the pharmacy workflow, further boosting the market. Moreover, recent developments in the pharmacy automation market have focused on enhancing reliability, precision, and ease of work.
For instance, in June 2022, Becton Dickinson (BD) bought Parata Systems from Frazier Healthcare Partners for USD 1.525 billion. The deal allows the medical technology giant to enter the pharmacy automation market, a space seeing strong growth as both established pharmacies and new digital-first entrants look to modernize workflow to improve efficiencies and cut costs.
Medication and dispensing errors are the result of poor communication between pharmacists and prescribers, and sometimes personal errors of pharmacists. Medication or dispensing errors include anomalies in drug substance, dose, dosage form, incorrect labelling, inappropriate packaging. Minimizing such errors can be challenging due to late realization of error. With automated pharmacy, dispensing errors can be minimized to zero, preventing any harm to patients. Based on a factsheet by the WHO in September 2023, one out of every thirty patients in healthcare are affected by medication-related harm, with more than 25% of this harm is considered as severe or dangerous to life. 50% of avoidable harm in healthcare is related to medications.
The pharmacy retail industry is demanding automation to improve the workflow and increase efficiency, owing to the increasing prevalence of chronic diseases. The increasing prevalence of chronic diseases is leading to an increasing volume of prescriptions on pharmacy counters. With a limited workforce, handling it can be a major challenge. Pharmacy automation helps in handling the huge volume of prescriptions with ease, ensuring patients receive their medicines with minimal error. As per an article published in Frontiers, by 2035, 35.66% of the adult population 50 years and older will have at least one chronic condition, which is expected to increase to 47.81% by 2050. Hence, the increasing prevalence of chronic diseases and prescription volume are the factors driving the pharmacy automation market.
The global pharmacy automation market has witnessed an increasing investment trend over the past few years. Many market players are developing automation tools to expedite innovation and productivity in pharmacy automation. Stakeholders are developing highly efficient pharmacy automation solutions to target the current shortcomings such as high volume of prescriptions and staff shortage. Private and public sectors are anticipating promising growth and revenue on their investments.
In October 2023, USD 9 million were invested in Plenful, a San Francisco-based firm that provides pharmacy technicians with workflow tools that automate manual and administrative tasks. The business stated that it has inked contracts with over 20 customers and concluded a USD 9 million investment round led by Bessemer Venture Partners.
The pandemic had a positive impact on the pharmacy automation market globally. The pandemic created a strong demand for the adoption of automation in pharmacy to reduce the workload on pharmacists. The COVID-19 pandemic led to a rapid increase in prescription volume that surged the demand for automation in pharmacies to ensure timely dispensing with limited staff. Pharmacy automation offered benefits such as speed, accuracy, and reliability during the pandemic. The demand for prescriptions was high during the pandemic as the workforce and supplies were running short. The success of pharmacy automation during the pandemic made industry realize its significance which led to further growth of pharmacy automation technology.
The global pharmacy automation market is highly competitive, with a few major players dominating the market. These players are Becton Dickison & Company, Capsa Solution LLC, and Omnicell Inc. These companies have a strong global presence, vast distribution network, and prioritize innovation. They are constantly investing in research and development to develop new technologies and products that meet the needs of their customers.
Synergy Medical introduced SynMed Ultra, a novel pharmacy automation system, in April 2023. This system can dispense oral drugs in blister packs at a high throughput. Filling more than 100 multi-dose blister packets in an hour, this automation system assists pharmacists in preparing medications for patients with precision.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work